← Leaderboards
Mark D. Mannie
East Carolina University
$4,044,876
Attributed
$4,044,876
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $728.1K · FY2011–20$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,044,876 · 3
By mechanism
R01$3,615,855 · 2
R15$429,021 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensMediatingVaccinesChimeric ProteinsParalysedIn VivoExperimental Autoimmune EncephalomyelitisMouse ModelPreventIn VitroProteinsInterferon-BetaT-LymphocyteMultiple SclerosisAdoptive TransferCytokineReporterRegulatory T-LymphocyteAdjuvantTransgenic OrganismsPhenotypeMyelinEpitopesExperimental Models
Grant awards (11)
Interferon-beta as an Adjuvant for Tolerogenic Vaccination$416,673
R01 · FY2020 · AI · contact PI
Interferon-beta as an Adjuvant for Tolerogenic Vaccination$416,673
R01 · FY2019 · AI · contact PI
Interferon-beta as an Adjuvant for Tolerogenic Vaccination$416,673
R01 · FY2018 · AI · contact PI
Interferon-beta as an Adjuvant for Tolerogenic Vaccination$416,673
R01 · FY2017 · AI · contact PI
Interferon-beta as an Adjuvant for Tolerogenic Vaccination$416,673
R01 · FY2016 · AI · contact PI
Interferons as adjuvants for tolerogenic vaccines$311,773
R01 · FY2015 · NS · contact PI
Interferons as adjuvants for tolerogenic vaccines$308,715
R01 · FY2014 · NS · contact PI
Interferons as adjuvants for tolerogenic vaccines$300,979
R01 · FY2013 · NS · contact PI
Interferons as adjuvants for tolerogenic vaccines$311,954
R01 · FY2012 · NS · contact PI
Therapeutic vaccines for treatment of experimental autoimmune encephalomyelitis ($429,021
R15 · FY2011 · NS · contact PI
Interferons as adjuvants for tolerogenic vaccines$299,069
R01 · FY2011 · NS · contact PI